Skip to main content
Clinical Trials/NCT00844584
NCT00844584
Unknown
Not Applicable

Clinical Study of Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope

Xijing Hospital1 site in 1 country20 target enrollmentOctober 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Xijing Hospital
Enrollment
20
Locations
1
Primary Endpoint
Electrocardiography
Last Updated
17 years ago

Overview

Brief Summary

Atrial fibrillation (AF) is a common supraventricular arrhythmia, the incidence of which increases with age. The aim of treatment of atrial fibrillation is to restore sinus rhythm and return the heart to atrioventricular synchrony, avoiding the risk of thromboembolism. The fact that pharmacological therapy of AF is at best 50% effective has led to a search for surgical approaches over the last 20 years.

Maze procedure was a classic method to treat AF. However, it is such a complex procedure that very few surgeons have adopted it. A few minimally invasive procedures to create transmural lesions which mimic MAZE procedure have been introduced. One of the mostly favored methods is catheter-based radiofrequency ablation, another one is video assisted epicardial radiofrequency ablation through small thoracic incisions in operating room.

Recently, we invented an epicardial radiofrequency ablation method under totally thoracoscope, which further minimized the surgery trauma and increased the cosmetic effect.

Registry
clinicaltrials.gov
Start Date
October 2008
End Date
June 2011
Last Updated
17 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Xijing Hospital

Eligibility Criteria

Inclusion Criteria

  • Any patients with atrial fibrillation

Exclusion Criteria

  • Patients with hemostasis defects
  • patients can not endure general anesthesia

Outcomes

Primary Outcomes

Electrocardiography

Time Frame: 2 years

Study Sites (1)

Loading locations...

Similar Trials